Phase III ASC4FIRST trial met both primary endpoints with clinically meaningful and statistically significant results; Scemblix® (asciminib) demonstrated superior MMR…
WALTHAM, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral…
Stone Mountain Health Services selects the AI-powered medical scribe to reduce physician burnoutWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR,…
The solution offers the only certified platform for pharmacy and provider collaboration to close gaps in care for quality score…
The new innovation helps improve healthcare employee retention and engagement through incentive-based rewardsOVERLAND PARK, Kan. & NEW YORK--(BUSINESS WIRE)--WellSky, a…
TAMPA, Fla.--(BUSINESS WIRE)--#AI--Looba.ai, a provider of artificial intelligence-based solutions for patients and providers, today announced an agreement with athenahealth, Inc.…
CellEDIT Service represents a novel workflow leveraging FluidFM-mediated intranuclear nanoinjection of CRISPR/Cas9 components into single cells.Control of the amount and…
SPG302 is being developed as a once-a-day pill with the potential to regenerate synapses to reverse declines in cognitive and…
The healthcare technology leader was recognized in 28 G2 Spring 2024 Reports and earned 9 badges in G2's spring report,…
I Am Boundless Inc. Focuses on Integration and Patient Outcomes Across 50+ Counties in the StateREMOTE-FIRST COMPANY/WORTHINGTON, Ohio--(BUSINESS WIRE)--#NextGenHealthcare--Driven by…